feed,title,long_url,short_url
SeekingAlpha,Enbridge: Buying More Of This 7%-Yielding Aristocrat For My Portfolio,https://seekingalpha.com/article/4692779,
SeekingAlpha,Icahn Enterprises: The 22% Yield Keeps Luring In Speculators,https://seekingalpha.com/article/4692706,
SeekingAlpha,Leap Therapeutics: The DisTinGuish Trial Provides A Near-Term Catalyst,https://seekingalpha.com/article/4692763,
